Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO)

Historical Holders from Q1 2024 to Q3 2025

Symbol
TELO on Nasdaq
CUSIP
87975F104
Type / Class
Equity / Common Stock, no par value
Shares outstanding
32.3M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
2.33M
Holdings value
$3.24M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
31
Number of buys
13
Number of sells
-29
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DEJORIA JOHN PAUL 5.5% $2.63M 1.77M John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity Sep 9, 2025

Institutional Holders of Telomir Pharmaceuticals, Inc. - Common Stock, no par value (TELO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 2.33M $3.24M -$617K $1.39 31
2025 Q2 2.81M $3.51M -$1.51M $1.25 42
2025 Q1 3.69M $11.9M +$378K $3.23 42
2024 Q4 3.56M $14.7M +$6.09M $4.12 36
2024 Q3 2.05M $13.1M +$9.01M $6.42 33
2024 Q2 361K $1.74M +$1.33M $4.81 24
2024 Q1 79.9K $413K +$413K $5.15 7